---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-301830"
form_type: "8-K"
ticker: "KURA"
cik: "0001422143"
company_name: "Kura Oncology, Inc."
filed_at: "2023-12-22T23:59:59+00:00"
generated_at: "2026-06-07T07:48:59.613225+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Kura Oncology adopts 2023 Inducement Option Plan reserving 600,000 shares for new hires

## Summary
- Plan reserves 600,000 shares of common stock for nonstatutory stock option grants to new employees as inducement material to employment.
- Awards must be approved by a majority of independent directors or independent compensation committee per Nasdaq Rule 5635(c)(4).
- Plan terms are substantially similar to the company's stockholder-approved Amended and Restated 2014 Equity Incentive Plan.

## SEC filing metadata
- accession: 0001193125-23-301830
- form_type: 8-K
- ticker: KURA
- cik: 0001422143
- company_name: Kura Oncology, Inc.
- filed_at: 2023-12-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1422143/000119312523301830/0001193125-23-301830-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1422143/000119312523301830/d675636d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-301830
- JSON: https://secwatch.observer/filing/0001193125-23-301830.json
- Plain text: https://secwatch.observer/filing/0001193125-23-301830.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.